Skip to Main Content

Paper Details

Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study.
Clin Cancer Res
15
2021
Author NameAffiliation
Alan H BryceMayo Clinic
Celestia S HiganoUniversity of Washington and Fred Hutchinson Cancer Research Center
Cora N SternbergEnglander Institute for Precision Medicine
Wassim AbidaMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2